sera obtained at enrollment in the study from patients suffering from moderate to sever dysplasia ( cervical intraepithelial neoplasia grade ii ) , carcinoma in situ ( cervical intraepithelial neoplasia grade iii ) and invasive carcinoma , or developing any of these conditions in the course of the prospective study , and from control subjects , were examined for herpes simplex type-2 ( hsv-2 ) antibody presence .
C0334047
moderate
C0349459
cervical intraepithelial neoplasia grade ii